Hrt Financial LP Assembly Biosciences, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.65 - $1.25 $19,836 - $38,147	30,518 New	30,518 $25,000
Q2 2022 Aug 12, 2022	SELL	$1.35 - $2.29 $11,040 - $18,727	-8,178 Reduced 28.0%	21,030 $44,000
Q1 2022 May 16, 2022	BUY	$1.46 - $2.45 $42,643 - $71,559	29,208 New	29,208 $60,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $272,869 - $338,913	-86,901 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $210,599 - $252,719	55,421 Added 176.05%	86,901 $337,000
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $11,842 - $18,133	2,735 Added 9.51%	31,480 $144,000
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $139,988 - $497,001	28,745 New	28,745 $173,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.